Cardiovascular Disease Mortality in Chronic Schizophrenia Patients Treated with Clozapine

BACKGROUND: Cardiovascular disease (CVD) mortality in schizophrenia is more frequent than in the general population. Whether second generation antipsychotics (SGAs) increase risk of CVD morbidity and mortality has yet to be determined. METHODS: Using an administrative database, we identified schizop...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kelly, Deanna L., McMahon, Robert P., Liu, Fang, Love, Raymond C., Wehring, Heidi, Shim, Joo Cheol, Warren, Kimberly R., Conley, Robert R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607426/
https://ncbi.nlm.nih.gov/pubmed/20079332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.08m04718yel
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak